These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37016445)

  • 21. Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
    Mokkink LB; Galindo-Garre F; Uitdehaag BM
    Mult Scler; 2016 Dec; 22(14):1867-1873. PubMed ID: 26873891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric properties of the Persian-version of the Activities-specific Balance Confidence scale and Fall Efficacy Scale-International in Iranian patients with multiple sclerosis.
    Monjezi S; Negahban H; Tajali S; Mofateh R; Molhemi F; Mostafaee N
    Physiother Theory Pract; 2021 Aug; 37(8):935-944. PubMed ID: 31455119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NIH Minimal Dataset for Chronic Low Back Pain: Responsiveness and Minimal Clinically Important Change.
    Dutmer AL; Reneman MF; Schiphorst Preuper HR; Wolff AP; Speijer BL; Soer R
    Spine (Phila Pa 1976); 2019 Oct; 44(20):E1211-E1218. PubMed ID: 31107833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
    Kim W; Park EY; Hyun JW; Huh SY; Park NY; Jang H; Kim SH; Kim HJ
    J Clin Neurol; 2020 Apr; 16(2):270-276. PubMed ID: 32319244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
    Taheri M; Negahban H; Mostafaee N; Salehi R; Tabesh H
    Disabil Rehabil; 2016; 38(5):482-6. PubMed ID: 25955822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do depressive and anxiety symptoms influence the construct validity of Multiple Sclerosis Walking Scale-12 scores?
    Šilić P; Jones CD; Jeng B; Motl RW
    Rehabil Psychol; 2024 May; 69(2):129-134. PubMed ID: 38166293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability, Validity, and Responsiveness of the Patient-Specific Functional Scale for Measuring Mobility-Related Goals in People With Multiple Sclerosis.
    Mañago MM; Cohen ET; Cameron MH; Christiansen CL; Bade M
    J Neurol Phys Ther; 2023 Jul; 47(3):139-145. PubMed ID: 36897202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.
    Filli L; Zörner B; Kapitza S; Reuter K; Lörincz L; Weller D; Sutter T; Killeen T; Gruber P; Petersen JA; Weller M; Linnebank M
    Neurology; 2017 Feb; 88(9):832-841. PubMed ID: 28148629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS.
    Hobart J; Blight AR; Goodman A; Lynn F; Putzki N
    Neurology; 2013 Apr; 80(16):1509-17. PubMed ID: 23535489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
    Learmonth YC; Dlugonski DD; Pilutti LA; Sandroff BM; Motl RW
    Mult Scler; 2013 Nov; 19(13):1784-91. PubMed ID: 23587605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
    Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
    Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability.
    Abasıyanık Z; Kahraman T; Ertekin Ö; Baba C; Özakbaş S
    Mult Scler Relat Disord; 2021 Apr; 49():102771. PubMed ID: 33493789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
    Marangoni BE; Pavan K; Tilbery CP
    Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group-based, individualized, comprehensive core stability and balance intervention provides immediate and long-term improvements in walking in individuals with multiple sclerosis: A randomized controlled trial.
    Arntzen EC; Straume B; Odeh F; Feys P; Normann B
    Physiother Res Int; 2020 Jan; 25(1):e1798. PubMed ID: 31268223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.